Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 438

1.

Eflornithine is safer than melarsoprol for the treatment of second-stage Trypanosoma brucei gambiense human African trypanosomiasis.

Chappuis F, Udayraj N, Stietenroth K, Meussen A, Bovier PA.

Clin Infect Dis. 2005 Sep 1;41(5):748-51. Epub 2005 Jul 19.

PMID:
16080099
2.

The treatment of human African trypanosomiasis.

Pépin J, Milord F.

Adv Parasitol. 1994;33:1-47. Review. No abstract available.

PMID:
8122565
3.

Melarsoprol versus eflornithine for treating late-stage Gambian trypanosomiasis in the Republic of the Congo.

Balasegaram M, Harris S, Checchi F, Ghorashian S, Hamel C, Karunakara U.

Bull World Health Organ. 2006 Oct;84(10):783-91.

4.

Gambian trypanosomiasis and synergism between melarsoprol and eflornithine: first case report.

Simarro PP, Asumu PN.

Trans R Soc Trop Med Hyg. 1996 May-Jun;90(3):315. No abstract available.

PMID:
8758090
5.

Melarsoprol-free drug combinations for second-stage Gambian sleeping sickness: the way to go.

Chappuis F.

Clin Infect Dis. 2007 Dec 1;45(11):1443-5. Epub 2007 Oct 22. No abstract available.

PMID:
17990226
6.

[A trial treatment with eflornithine of trypanosomiasis caused by Trypanosoma brucei gambiense in the Peoples Republic of the Congo].

Eozenou P, Jannin J, Ngampo S, Carme B, Tell GP, Schechter PJ.

Med Trop (Mars). 1989 Apr-Jun;49(2):149-54. French.

PMID:
2507863
7.

Cost-effectiveness analysis of alternative treatments of African gambiense trypanosomiasis in Uganda.

Politi C, Carrín G, Evans D, Kuzoe FA, Cattand PD.

Health Econ. 1995 Jul-Aug;4(4):273-87.

PMID:
8528430
8.

Production of sleeping-sickness treatment.

Pécoul B, Gastellu M.

Lancet. 1999 Sep 11;354(9182):955-6. No abstract available.

PMID:
10489988
9.

Treatment outcomes and risk factors for relapse in patients with early-stage human African trypanosomiasis (HAT) in the Republic of the Congo.

Balasegaram M, Harris S, Checchi F, Hamel C, Karunakara U.

Bull World Health Organ. 2006 Oct;84(10):777-82.

10.

Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo.

Priotto G, Kasparian S, Ngouama D, Ghorashian S, Arnold U, Ghabri S, Karunakara U.

Clin Infect Dis. 2007 Dec 1;45(11):1435-42. Epub 2007 Oct 22.

PMID:
17990225
11.

Eflornithine is a cost-effective alternative to melarsoprol for the treatment of second-stage human West African trypanosomiasis in Caxito, Angola.

Robays J, Raguenaud ME, Josenando T, Boelaert M.

Trop Med Int Health. 2008 Feb;13(2):265-71. doi: 10.1111/j.1365-3156.2007.01999.x.

12.

Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine Médecins Sans Frontières programmes.

Balasegaram M, Young H, Chappuis F, Priotto G, Raguenaud ME, Checchi F.

Trans R Soc Trop Med Hyg. 2009 Mar;103(3):280-90. doi: 10.1016/j.trstmh.2008.09.005. Epub 2008 Oct 22.

PMID:
18947846
13.
14.

Eflornithine for the treatment of human African trypanosomiasis.

Burri C, Brun R.

Parasitol Res. 2003 Jun;90 Supp 1:S49-52. Epub 2002 Dec 10. Review.

PMID:
12811548
15.

Risk factors for treatment failure after melarsoprol for Trypanosoma brucei gambiense trypanosomiasis in Uganda.

Legros D, Evans S, Maiso F, Enyaru JC, Mbulamberi D.

Trans R Soc Trop Med Hyg. 1999 Jul-Aug;93(4):439-42.

PMID:
10674099
16.

Treatment of human African trypanosomiasis--present situation and needs for research and development.

Legros D, Ollivier G, Gastellu-Etchegorry M, Paquet C, Burri C, Jannin J, Büscher P.

Lancet Infect Dis. 2002 Jul;2(7):437-40. Review.

PMID:
12127356
17.

Current chemotherapy of human African trypanosomiasis.

Docampo R, Moreno SN.

Parasitol Res. 2003 Jun;90 Supp 1:S10-3. Epub 2002 Nov 23. Review.

PMID:
12811544
18.

Equivalence trial of melarsoprol and nifurtimox monotherapy and combination therapy for the treatment of second-stage Trypanosoma brucei gambiense sleeping sickness.

Bisser S, N'Siesi FX, Lejon V, Preux PM, Van Nieuwenhove S, Miaka Mia Bilenge C, Būscher P.

J Infect Dis. 2007 Feb 1;195(3):322-9. Epub 2006 Dec 21.

PMID:
17205469
19.

Human African trypanosomiasis: diagnosis, relapse and survival after severe melarsoprol-induced encephalopathy.

Checkley AM, Pepin J, Gibson WC, Taylor MN, Jäger HR, Mabey DC.

Trans R Soc Trop Med Hyg. 2007 May;101(5):523-6. Epub 2007 Jan 31.

PMID:
17270227
20.

Advances in sleeping sickness therapy.

Van Nieuwenhove S.

Ann Soc Belg Med Trop. 1992;72 Suppl 1:39-51.

PMID:
1417168

Supplemental Content

Support Center